stockrowNuwellis, Inc.
NUWENuwellis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.3 million, down 5.38% from fiscal 2024.
- Revenue
- +14.1%
- EPS
- +98.8%
- Free cash flow
- −51.6%
Quarter to June 2026, against a year earlier
Follow NUWE
Alert me
Nuwellis, Inc. (NUWE) Return on invested capital
Nuwellis, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 0.00%, up 449.3 percentage points from fiscal 2025 (−449.3%). Over the past ten years it has ranged from −2,335.0% (fiscal 2018) to 0.00% (fiscal 2023); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of −5.22% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −449.3% | 29.30 |
| FY2024 | −478.6% | (478.57) |
| FY2023 | 0.00% | 0.00 |
| FY2022 | 0.00% | 689.48 |
| FY2021 | −689.5% | (139.48) |
| FY2020 | −550.0% | 614.22 |
| FY2019 | −1,164.2% | 1,170.76 |
| FY2018 | −2,335.0% | (895.24) |
| FY2017 | −1,439.7% | (374.59) |
| FY2016 | −1,065.2% | (1,065.15) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| NUWE Nuwellis, Inc. | 0.00% |
| AIDX 20/20 Biolabs Inc. compare | 0.00% |
| AMIX Autonomix Medical, Inc. compare | 0.00% |
| BJDX Bluejay Diagnostics, Inc. compare | 0.00% |
| ICCM IceCure Medical Ltd. compare | 0.00% |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | 0.00% |
| IVF INVO Fertility, Inc compare | −27.9% |
| CODX Co-Diagnostics, Inc. compare | −337.7% |
| VVOS Vivos Therapeutics, Inc. compare | −592.7% |
| Medical Devices industry median | −5.22% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)